CPhi Preview 2013: AbbVie - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

CPhi Preview 2013: AbbVie

Untitled Document

2013 CPhI Exhibitor Preview

Company: AbbVie

Description: Through its rich heritage from its predecessor, AbbVie has been in the Contract Manufacturing business for over 25 years.  We offer are customers with high-quality, innovative, cost-effective services in the area of Biologics, Potent, Drug Product and Bulk Active Pharmaceutical Ingredients to benefit the companies that put their trust in us.  

Website: www.abbviecontractmfg.com

Booth Number: 42K39


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here